1
A Phase 1 Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function
Condition(s):Normal and Impaired Renal FunctionLast Updated:November 18, 2015Completed
MTP-131: 25 Clinical Trials, Page 1 of 3
Hide Studies Not Open or Pending
2
A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration
Condition(s):Diabetic Macular Edema; Age-related Macular DegenerationLast Updated:October 26, 2015Completed
3
A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Bendavia™ (MTP-131) in Patients With Heart Failure
Condition(s):Heart FailureLast Updated:October 15, 2015Withdrawn
4
Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of Intravenous (IV) Infusion of MTP-131 (Bendavia™) in Healthy Adults
Condition(s):HealthyLast Updated:November 18, 2010Completed
5
Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events
Condition(s):Reperfusion Injury; STEMILast Updated:June 11, 2020Completed
6
A Study Investigating the Safety, Tolerability, and Pharmacokinetics of MTP-131 in Subjects With Congestive Heart Failure
Condition(s):Congestive Heart FailureLast Updated:September 17, 2015Completed
7
A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly
Condition(s):Skeletal Muscle Mitochondrial Dysfunction in the ElderlyLast Updated:June 23, 2020Completed
8
Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy
Condition(s):Mitochondrial MyopathyLast Updated:December 27, 2019Completed
9
Safety, Tolerability, Efficacy of MTP-131 for Treatment of Mitochondrial Disease in Subjects From the MMPOWER Study
Condition(s):Primary Mitochondrial DiseaseLast Updated:July 17, 2020Completed
10
A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber’s Hereditary Optic Neuropathy
Condition(s):Leber’s Hereditary Optic NeuropathyLast Updated:November 30, 2021Completed